Tandem Diabetes Care Inc (TNDM)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.40B
Last updated: Nov 17, 2026 at 4:15 PM ET
Tandem Diabetes Care Inc (TNDM) Statistics
Tandem Diabetes Care (TNDM) has a market cap of $1.40B and an enterprise value of $1.93B. It earned -$49.23M on revenue of $1.08B over the last 12 months.
Total Valuation
Enterprise value is 37.88% above the market cap, as debt exceeds cash.
| Market Cap | $1.40B |
|---|---|
| Enterprise Value | $1.93B |
| Latest price (Nov 17, 2026) | $17.06 |
Key Dates
The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.1x and 8.8x. Its year-end P/S ranged from 0.1x to 13.6x from 2016 to 2025.
| P/S Ratio | 1.1x |
|---|---|
| Forward P/S | 1.3x |
| P/B Ratio | 8.8x |
Price Statistics
The stock is down 8.33% over 52 weeks and trades 1.44% below its 50-day average.
| Beta (1Y) | 1.19 |
|---|---|
| 52-Week Change | -8.33% |
| 1-Month Change | +4.15% |
| 3-Month Change | -27.28% |
| 6-Month Change | +23.09% |
| 5-Year Change | -85.98% |
| 10-Year Change | -68.41% |
| Total Return (1Y) | -8.33% |
| Total Return (3Y CAGR) | -1.39% |
| Total Return (5Y CAGR) | -34.09% |
| Return vs SPY (1Y) | -20.38% |
| Max Drawdown (1Y) | -54.64% |
| Max Drawdown (3Y) | -81.07% |
| Sharpe Ratio (1Y) | -0.13 |
| Correlation with SPY (1Y) | 0.22 |
| 50-Day Average | $17.31 |
| 200-Day Average | $18.82 |
| 52-Week Range | $12.26 to $29.65 |
| RSI (14 Days) | 45.9 |
| Average Volume (20 Days) | 2.83M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.21x current liabilities, and total debt is 4.47x shareholder equity.
| Current Ratio | 3.21x |
|---|---|
| Quick Ratio | 2.65x |
| Debt / Equity | 4.47x |
| Interest Coverage | -2.80x |
Returns and Efficiency
Return on invested capital is -3.43% over the last 12 months, against a 5-year average of -31.80%.
| Return on Equity (ROE) | -36.45% |
|---|---|
| Return on Assets (ROA) | -4.25% |
| Return on Invested Capital (ROIC) | -3.43% |
| Return on Capital Employed (ROCE) | -2.80% |
| ROE (5Y Average) | -51.46% |
| ROA (5Y Average) | -12.76% |
| ROIC (5Y Average) | -31.80% |
| Asset Turnover | 1.06x |
| Inventory Turnover | 3.35x |
| Receivables Turnover | 6.29x |
| Cash Conversion Cycle | 113 days |
Scores
TNDM has an Altman Z-Score of 0.57, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.57 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.08B over the last 12 months is up 6.84% from the 12 months before.
| Revenue | $1.08B |
|---|---|
| Revenue Growth (YoY) | +6.84% |
| Gross Profit | $609.45M |
| Operating Income | -$25.30M |
| Pretax Income | -$43.55M |
| Net Income | -$49.23M |
| EBITDA | -$9.17M |
| EBIT | -$25.30M |
| Reported EPS (TTM) | -$0.72 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 11.65% of the $1.16B in total assets.
| Cash and Equivalents | $72.84M |
|---|---|
| Total Debt | $603.39M |
| Net Debt | $530.55M |
| Net Debt Per Share | $7.62 |
| Working Capital | $564.65M |
| Shareholder Equity | $135.09M |
| Book Value Per Share | $1.94 |
| Total Assets | $1.16B |
| Total Liabilities | $1.02B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $21.69M of capital spending, operating cash flow left -$36.30M of free cash flow.
| Operating Cash Flow | -$14.61M |
|---|---|
| Capital Expenditures | $21.69M |
| Free Cash Flow | -$36.30M |
| FCF Per Share | -$0.52 |
| Depreciation and Amortization | $19.83M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -2.35%, against a 5-year average of -13.71%.
| Gross Margin | 56.65% |
|---|---|
| Operating Margin | -2.35% |
| Pretax Margin | -4.05% |
| Net Margin | -4.58% |
| EBITDA Margin | -0.85% |
| EBIT Margin | -2.35% |
| FCF Margin | -3.37% |
| Gross Margin (5Y Average) | 52.03% |
| Operating Margin (5Y Average) | -13.71% |
| Net Margin (5Y Average) | -13.95% |
Growth
Revenue grew 8.19% a year over 3 years.
| Revenue Growth (3Y CAGR) | +8.19% |
|---|---|
| Revenue Growth (5Y CAGR) | +15.26% |
| Book Value Per Share Growth (2Y CAGR) | -31.04% |
| Tangible Book Per Share Growth (2Y CAGR) | -31.04% |
Dividends and Yields
TNDM does not pay a dividend. Its free cash flow yield is -3.05%.
| FCF Yield | -3.05% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-10 reverse split on Oct 10, 2017.
| Last Split Date | Oct 10, 2017 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Peer Position
Against 12 similar companies, TNDM has the 10th highest P/S.
P/S RatioPeer median 3.3x
ROICPeer median -16.70%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.46%
| P/S Ratio | 1.1x vs 3.3x median |
|---|---|
| ROIC | -3.43% vs -16.70% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +6.84% vs +13.46% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.77% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.77% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About TNDM
What is TNDM's market cap?
Tandem Diabetes Care has a market cap of $1.40B. Its enterprise value, which adds debt and subtracts cash, is $1.93B.
How many shares of TNDM are outstanding?
Tandem Diabetes Care has 69.65M shares outstanding. The count is up 2.95% from a year earlier.
Does TNDM pay a dividend?
No. Tandem Diabetes Care does not pay a dividend.
How much debt does TNDM have?
Tandem Diabetes Care has $603.39M of total debt and $72.84M of cash and equivalents, a net debt position of $530.55M.
TNDM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors